We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Innospec (IOSP) Upgraded to Buy on Healthy Q1 and Prospects
Read MoreHide Full Article
On May 16, Zacks Investment Research upgraded chemical maker, Innospec Inc. (IOSP - Free Report) to a Zacks Rank #2 (Buy). Going by the Zacks model, companies carrying a Zacks Rank #2 have higher chances of outperforming the broader market.
Why the Upgrade?
Innospec posted a profit of $17.2 million or 70 cents per share in first-quarter 2017, down around 9% from $18.9 million or 77 cents a year ago. Barring one-time items, earnings were $1.00 per share for the quarter, coming ahead of the Zacks Consensus Estimate of 95 cents.
The company’s revenues grew 39% year over year to $294.3 million in the quarter. The company witnessed higher sales across core business segments in the reported quarter.
Innospec is well positioned to record strong growth in all its businesses. The company will continue to integrate its recent acquisitions and will also pursue other strategic buyouts to boost its portfolio.
In the first quarter, Innospec noted that demand across Performance Chemicals, Oilfield Services and Octane Additives segments improved greatly. While sales of Performance Chemicals jumped three-fold year over year on the back of recent acquisitions, revenues from Oilfield Services and Octane Additives units surged 84% and 61% year over year, respectively, in the quarter.
The company also hiked its semi-annual dividend by 15% to 38 cents per common share for first-half 2017. The dividend will be paid on May 31 to shareholders of record as of May 22.
Innospec’s shares have also rallied 34.7% in the last one year, outperforming the Zacks categorized Chemicals-Diversified industry’s gain of 18.6%.
Kronos has an expected long-term earnings growth of 5%.
Methanex has an expected long-term earnings growth of 15%.
ArcelorMittal has an expected long-term earnings growth of 11.4%.
Will You Make a Fortune on the Shift to Electric Cars?
Here's another stock idea to consider. Much like petroleum 150 years ago, lithium power may soon shake the world, creating millionaires and reshaping geo-politics. Soon electric vehicles (EVs) may be cheaper than gas guzzlers. Some are already reaching 265 miles on a single charge.
With battery prices plummeting and charging stations set to multiply, one company stands out as the #1 stock to buy according to Zacks research.
Image: Bigstock
Innospec (IOSP) Upgraded to Buy on Healthy Q1 and Prospects
On May 16, Zacks Investment Research upgraded chemical maker, Innospec Inc. (IOSP - Free Report) to a Zacks Rank #2 (Buy). Going by the Zacks model, companies carrying a Zacks Rank #2 have higher chances of outperforming the broader market.
Why the Upgrade?
Innospec posted a profit of $17.2 million or 70 cents per share in first-quarter 2017, down around 9% from $18.9 million or 77 cents a year ago. Barring one-time items, earnings were $1.00 per share for the quarter, coming ahead of the Zacks Consensus Estimate of 95 cents.
The company’s revenues grew 39% year over year to $294.3 million in the quarter. The company witnessed higher sales across core business segments in the reported quarter.
Innospec Inc. Price and Consensus
Innospec Inc. Price and Consensus | Innospec Inc. Quote
Innospec is well positioned to record strong growth in all its businesses. The company will continue to integrate its recent acquisitions and will also pursue other strategic buyouts to boost its portfolio.
In the first quarter, Innospec noted that demand across Performance Chemicals, Oilfield Services and Octane Additives segments improved greatly. While sales of Performance Chemicals jumped three-fold year over year on the back of recent acquisitions, revenues from Oilfield Services and Octane Additives units surged 84% and 61% year over year, respectively, in the quarter.
The company also hiked its semi-annual dividend by 15% to 38 cents per common share for first-half 2017. The dividend will be paid on May 31 to shareholders of record as of May 22.
Innospec’s shares have also rallied 34.7% in the last one year, outperforming the Zacks categorized Chemicals-Diversified industry’s gain of 18.6%.
Other Stocks to Consider
Other top ranked companies in the basic materials space include Kronos Worldwide, Inc. (KRO - Free Report) , Methanex Corporation (MEOH - Free Report) and ArcelorMittal (MT - Free Report) . All the three stocks sport a Zacks Rank #1 (Strong Buy). You can see the complete list of today’s Zacks Rank #1 stocks here.
Kronos has an expected long-term earnings growth of 5%.
Methanex has an expected long-term earnings growth of 15%.
ArcelorMittal has an expected long-term earnings growth of 11.4%.
Will You Make a Fortune on the Shift to Electric Cars?
Here's another stock idea to consider. Much like petroleum 150 years ago, lithium power may soon shake the world, creating millionaires and reshaping geo-politics. Soon electric vehicles (EVs) may be cheaper than gas guzzlers. Some are already reaching 265 miles on a single charge.
With battery prices plummeting and charging stations set to multiply, one company stands out as the #1 stock to buy according to Zacks research.
It's not the one you think. See This Ticker Free >>